LEXICON PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 106.27 million shares for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-03-12
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 106.27M shares, a 0.40% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 106.05M shares, a 0.37% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-12-31 was 105.92M shares, a 0.31% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 105.88M shares, a 0.28% increase year-over-year.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 105.83M shares, a 0.56% increase from fiscal 2017.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 105.24M shares, a 1.32% increase from fiscal 2016.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 103.86M shares, a 0.26% increase from fiscal 2015.
- LEXICON PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 103.59M shares, a 35.68% increase from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | 106.27M shares 10-Q · filed 2019-08-01 | 106.16M shares 10-Q · filed 2019-08-01 | 106.08M shares derived: average of 3 quarters · filed 2020-03-12 | 106.03M shares derived: average of 4 quarters · filed 2020-03-12 | ||||
| 2019-03-31 | 106.05M shares 10-Q · filed 2019-05-01 | 105.99M shares derived: average of 2 quarters · filed 2020-03-12 | 105.95M shares derived: average of 3 quarters · filed 2020-03-12 | 105.93M shares derived: average of 4 quarters · filed 2020-03-12 | ||||
| 2018-12-31 | 105.92M shares 10-K · filed 2020-03-12 | 105.90M shares derived: average of 2 quarters · filed 2020-03-12 | 105.88M shares derived: average of 3 quarters · filed 2020-03-12 | 105.83M shares 10-K · filed 2019-03-15 | ||||
| 2018-09-30 | 105.88M shares 10-K · filed 2020-03-12 | 105.86M shares derived: average of 2 quarters · filed 2020-03-12 | 105.80M shares 10-Q · filed 2018-11-01 | 105.75M shares derived: average of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | 105.85M shares 10-K · filed 2020-03-12 | 105.76M shares 10-Q · filed 2019-08-01 | 105.70M shares derived: average of 3 quarters · filed 2020-03-12 | 105.67M shares derived: average of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | 105.67M shares 10-K · filed 2020-03-12 | 105.63M shares derived: average of 2 quarters · filed 2020-03-12 | 105.61M shares derived: average of 3 quarters · filed 2020-03-12 | 105.53M shares derived: average of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | 105.59M shares 10-K · filed 2019-03-15 | 105.58M shares derived: average of 2 quarters · filed 2019-03-15 | 105.49M shares derived: average of 3 quarters · filed 2019-03-15 | 105.24M shares 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | 105.58M shares 10-K · filed 2019-03-15 | 105.44M shares derived: average of 2 quarters · filed 2019-03-15 | 105.12M shares 10-Q · filed 2018-11-01 | 104.85M shares derived: average of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | 105.30M shares 10-K · filed 2019-03-15 | 104.88M shares 10-Q · filed 2018-07-30 | 104.60M shares derived: average of 3 quarters · filed 2019-03-15 | 104.42M shares derived: average of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | 104.46M shares 10-K · filed 2019-03-15 | 104.26M shares derived: average of 2 quarters · filed 2019-03-15 | 104.13M shares derived: average of 3 quarters · filed 2019-03-15 | 104.06M shares derived: average of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | 104.05M shares 10-K · filed 2018-03-01 | 103.97M shares derived: average of 2 quarters · filed 2018-03-01 | 103.92M shares derived: average of 3 quarters · filed 2018-03-01 | 103.86M shares 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | 103.89M shares 10-K · filed 2018-03-01 | 103.86M shares derived: average of 2 quarters · filed 2018-03-01 | 103.80M shares 10-Q · filed 2017-11-08 | 103.76M shares derived: average of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | 103.83M shares 10-K · filed 2018-03-01 | 103.76M shares 10-Q · filed 2017-08-01 | 103.71M shares derived: average of 3 quarters · filed 2018-03-01 | 103.69M shares derived: average of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | 103.68M shares 10-K · filed 2018-03-01 | 103.65M shares derived: average of 2 quarters · filed 2018-03-01 | 103.64M shares derived: average of 3 quarters · filed 2018-03-01 | 103.63M shares derived: average of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | 103.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 103.62M shares derived: average of 2 quarters · filed 2018-03-01 | 103.62M shares derived: average of 3 quarters · filed 2018-03-01 | 103.59M shares 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | 103.62M shares 10-Q · filed 2016-11-07 | 103.61M shares derived: average of 2 quarters · filed 2016-11-07 | 103.58M shares 10-Q · filed 2016-11-07 | 98.89M shares derived: average of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | 103.61M shares 10-Q · filed 2016-08-04 | 103.56M shares 10-Q · filed 2016-08-04 | 97.31M shares derived: average of 3 quarters · filed 2016-08-04 | 91.37M shares derived: average of 4 quarters · filed 2016-08-04 | ||||
| 2015-03-31 | 103.52M shares 10-Q · filed 2016-05-05 | 724.61M shares 10-Q · filed 2015-05-05 | 94.16M shares derived: average of 2 quarters · filed 2016-05-05 | 87.29M shares derived: average of 3 quarters · filed 2016-05-05 | 83.85M shares derived: average of 4 quarters · filed 2016-05-05 | |||
| 2014-12-31 | 84.81M shares 10-K · filed 2016-03-11 | 593.69M shares 10-K · filed 2015-03-12 | 79.18M shares derived: average of 2 quarters · filed 2016-03-11 | 77.29M shares derived: average of 3 quarters · filed 2016-03-11 | 76.35M shares 10-K · filed 2017-03-06 | 534.43M shares 10-K · filed 2015-03-12 | ||
| 2014-09-30 | 73.54M shares 10-K · filed 2016-03-11 | 514.80M shares 10-Q · filed 2014-11-06 | 73.53M shares derived: average of 2 quarters · filed 2016-03-11 | 73.49M shares 10-Q · filed 2015-11-09 | 514.46M shares 10-Q · filed 2014-11-06 | 183.50M shares derived: average of 4 quarters · filed 2016-03-11 | ||
| 2014-06-30 | 73.52M shares 10-K · filed 2016-03-11 | 514.62M shares 10-Q · filed 2014-08-07 | 73.47M shares 10-Q · filed 2015-08-07 | 514.29M shares 10-Q · filed 2014-08-07 | 220.15M shares derived: average of 3 quarters · filed 2016-03-11 | 293.47M shares derived: average of 4 quarters · filed 2016-03-11 | ||
| 2014-03-31 | 73.42M shares 10-K · filed 2016-03-11 | 513.96M shares 10-Q · filed 2014-05-08 | 293.47M shares derived: average of 2 quarters · filed 2016-03-11 | 366.79M shares derived: average of 3 quarters · filed 2016-03-11 | 403.36M shares derived: average of 4 quarters · filed 2016-03-11 | |||
| 2013-12-31 | 513.52M shares 10-K · filed 2015-03-12 | 513.47M shares derived: average of 2 quarters · filed 2015-03-12 | 513.34M shares derived: average of 3 quarters · filed 2015-03-12 | 73.30M shares 10-K · filed 2016-03-11 | 513.12M shares 10-K · filed 2014-03-07 | |||
| 2013-09-30 | 513.42M shares 10-K · filed 2015-03-12 | 513.25M shares derived: average of 2 quarters · filed 2015-03-12 | 512.98M shares 10-Q · filed 2014-11-06 | 511.64M shares derived: average of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | 513.08M shares 10-K · filed 2015-03-12 | 512.76M shares 10-Q · filed 2014-08-07 | 511.04M shares derived: average of 3 quarters · filed 2015-03-12 | 505.79M shares derived: average of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | 512.43M shares 10-K · filed 2015-03-12 | 510.02M shares derived: average of 2 quarters · filed 2015-03-12 | 503.37M shares derived: average of 3 quarters · filed 2015-03-12 | 497.68M shares derived: average of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | 507.62M shares 10-K · filed 2014-03-07 | 498.83M shares derived: average of 2 quarters · filed 2014-03-07 | 492.77M shares derived: average of 3 quarters · filed 2014-03-07 | 489.71M shares 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | 490.05M shares 10-K · filed 2014-03-07 | 485.34M shares derived: average of 2 quarters · filed 2014-03-07 | 483.69M shares 10-Q · filed 2013-11-12 | 450.27M shares derived: average of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | 480.63M shares 10-K · filed 2014-03-07 | 480.48M shares 10-Q · filed 2013-08-01 | 437.01M shares derived: average of 3 quarters · filed 2014-03-07 | 412.18M shares derived: average of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | 480.32M shares 10-K · filed 2014-03-07 | 415.20M shares derived: average of 2 quarters · filed 2014-03-07 | 389.36M shares derived: average of 3 quarters · filed 2014-03-07 | 376.43M shares derived: average of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | 350.07M shares 10-K · filed 2013-03-11 | 343.87M shares derived: average of 2 quarters · filed 2013-03-11 | 341.81M shares derived: average of 3 quarters · filed 2013-03-11 | 340.76M shares 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | 337.68M shares 10-K · filed 2013-03-11 | 337.67M shares derived: average of 2 quarters · filed 2013-03-11 | 337.62M shares derived: average of 3 quarters · filed 2013-03-11 | |||||
| 2011-06-30 | 337.67M shares 10-K · filed 2013-03-11 | 337.60M shares derived: average of 2 quarters · filed 2013-03-11 | ||||||
| 2011-03-31 | 337.53M shares 10-K · filed 2013-03-11 | |||||||
| 2010-12-31 | 302.84M shares 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |